Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lorenza Palmero
Observed names:
L. Palmero,
lorenza Palmero
Institution:
Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo
Observed institutions:
University of Udine,
Centro di Riferimento Oncologico,
Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo,
Azienda sanitaria universitaria Friuli Centrale
ORCID:
0000-0003-4829-6966
Observed ORCID:
0000-0003-4829-6966
OpenAlex ID:
A5011692796
BRAF and MEK Inhibitors and Their Toxicities: A Meta-Analysis
2022
·
Mattia Garutti
, Melissa Bergnach
, et al.
·
Cancers
·
104
PDF
CDK4/6 Inhibitors in Melanoma: A Comprehensive Review
2021
·
Mattia Garutti
, Giada Targato
, et al.
·
Cells
·
79
PDF
NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome
2021
·
Anna Michelotti
, Marco de Scordilli
, et al.
·
Cells
·
48
PDF
Liquid biopsy in triple-negative breast cancer: unlocking the potential of precision oncology
2024
·
R. Mazzeo
, J. Sears
, et al.
·
ESMO Open
·
38
PDF
First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study
2021
·
Debora Basile
, Lorenzo Gerratana
, et al.
·
The Breast
·
38
PDF
An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer
2022
·
Rossana Roncato
, Lorenzo Gerratana
, et al.
·
Frontiers in Pharmacology
·
27
PDF
Multidisciplinary Team Meeting Proposal and Final Therapeutic Choice in Early Breast Cancer: Is There an Agreement?
2022
·
Lucia Bortot
, Giada Targato
, et al.
·
Frontiers in Oncology
·
11
PDF
Preoperative treatments in borderline resectable and locally advanced pancreatic cancer: Current evidence and new perspectives
2023
·
Marco de Scordilli
, Anna Michelotti
, et al.
·
Critical Reviews in Oncology/Hematology
·
7
Estimating survival in patients with melanoma brain metastases: prognostic value of lactate dehydrogenase
2023
·
Giacomo Pelizzari
, Elisa Bertoli
, et al.
·
Melanoma Research
·
4
800P Number needed to treat (NNT) and number needed to harm (NNH) to estimate clinical efficacy and safety of new adjuvant (Adj) therapies for resected stage (St) II-III melanoma
2022
·
D. Zara
, B. Pastò
, et al.
·
Annals of Oncology
·
4
295P Clinical characterization and outcome of a HER2-low metastatic breast cancer (mBC) cohort receiving first-line treatment (1L) with ET +/- CDK 4/6 inhibitor (CDKi)
2021
·
L. Bortot
, D. Basile
, et al.
·
Annals of Oncology
·
4
Refining neutropenia risk assessment in patients treated with first-line endocrine therapy (ET) and cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) for metastatic breast cancer (MBC) through a cell-free DNA workflow (cfDNA).
2021
·
Lorenza Palmero
, Roberta Mazzeo
, et al.
·
Journal of Clinical Oncology
·
4
1741P Triage procedures for COVID-19 in an Italian cancer centre
2020
·
G. Targato
, D. Zara
, et al.
·
Annals of Oncology
·
2
PDF
Impact of sarcopenia in patients with metastatic melanoma treated with immunotherapy
2019
·
M.G. Vitale
, D. Basile
, et al.
·
Annals of Oncology
·
2
Hospital as a site of death of cancer patients in Italy: A registry-based analysis and time trends
2024
·
Gianmauro Numico
, Roberto Ippoliti
, et al.
·
Cancer Epidemiology
·
1
261P Liquid biopsy–based biomarkers for the characterization of hormone receptor-positive (HR+) HER2-Low metastatic breast cancer (mBC)
2022
·
L. Bortot
, D. Basile
, et al.
·
Annals of Oncology
·
1
PDF
Clinical decision making and multidisciplinary team meetings (MDMs) in early breast cancer. Is the agreement between planned and applied therapeutic program?
2019
·
M. Giavarra
, E. Bertoli
, et al.
·
Annals of Oncology
·
1
Mismatch repair protein expression in lynch-associated neoplasms: analysis of 173 patients with endometrial cancer
2026
·
Marinella Destefanis
, Elena Olearo
, et al.
·
International Journal of Gynecological Cancer
Unlocking biomarkers' prognostic, predictive and preventive power: the case manager’s role in personalized gynecologic oncology pathways
2026
·
Marinella Destefanis
, Carmelo Calidona
, et al.
·
International Journal of Gynecological Cancer
Mirvetuximab in proc FRα-high: A promising therapeutic strategy
2026
·
Marinella Destefanis
, Elena Olearo
, et al.
·
International Journal of Gynecological Cancer
POLE-mutated endometrial cancer: from genomics to clinical reality
2026
·
Marinella Destefanis
, Carmelo Calidona
, et al.
·
International Journal of Gynecological Cancer
ESR1 mutation: A potential preventive biomarker in endometrial cancer?
2026
·
Marinella Destefanis
, Elena Olearo
, et al.
·
International Journal of Gynecological Cancer
The crucial role of the geneticist in gynecologic oncology
2026
·
Marinella Destefanis
, Carmelo Calidona
, et al.
·
International Journal of Gynecological Cancer
Predictors of duration of hospital stay for cancer patients admitted due to medical causes: A quality-improvement evaluation
2025
·
Gianmauro Numico
, Elena Fea
, et al.
·
Tumori Journal
Cervical Necrosis After Radical Chemoradiation For Cervical Cancer And Correlated Risk Factors In A Mono-Institutional Series
2025
·
Francesco Olivero
, Stefania Martini
, et al.
·
International Journal of Gynecological Cancer
PDF
Show more works
View as search
Works count:
39
Citation count:
375
H-index:
7
I10-index:
7
Year
Topic
Type